SIP
LLY icon

Stoneridge Investment Partners’s Eli Lilly LLY Stock Holding History

Stoneridge Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,450
Closed -$1.26M – 120
2021
Q3 		$1.26M Buy
+5,450
New +$1.35M 0.63% 44
2016
Q3 		– Sell
-2,953
Closed -$233K – 299
2016
Q2 		$233K Buy
+2,953
New +$222K 0.03% 245

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stoneridge Investment Partners's LLY Position: Q4 2021 in Review

Stoneridge Investment Partners sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 5,450 shares — an estimated $1.26M sold.

Stoneridge Investment Partners first reported a position in LLY in Q2 2016 and held it in 2 quarters. The position peaked at $1.26M in Q3 2021. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • Stoneridge Investment Partners reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
  • Stoneridge Investment Partners sold 5,450 Eli Lilly shares in Q4 2021, an estimated $1.26M.
  • Stoneridge Investment Partners first reported a position in Eli Lilly in Q2 2016 and held it in 2 quarters.
  • Stoneridge Investment Partners's Eli Lilly position peaked at $1.26M in Q3 2021.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Stoneridge Investment Partners's 13F filing for Q4 2021, filed 2 Feb 2022.